Nasopharyngeal carcinoma: A new synthesis of literature data

D Jicman, E Niculet, M Lungu… - Experimental and …, 2022 - spandidos-publications.com
Nasopharyngeal carcinoma (NPC) is an epithelial tumor, which develops most frequently
from the lateral pharyngeal recess and holds some complex epidemiological characteristics …

Infantile hemangiomas: an update on pathogenesis and treatment

M Kowalska, W Dębek, E Matuszczak - Journal of clinical medicine, 2021 - mdpi.com
Infantile hemangiomas are the most common benign vascular tumors in infancy. This review
includes an update on the current knowledge on pathogenesis, a discussion on indications …

Modulation of neurotrophic factors in the treatment of dementia, stroke and TBI: Effects of Cerebrolysin

K Rejdak, H Sienkiewicz‐Jarosz… - Medicinal Research …, 2023 - Wiley Online Library
Neurotrophic factors (NTFs) are involved in the pathophysiology of neurological disorders
such as dementia, stroke and traumatic brain injury (TBI), and constitute molecular targets of …

Das Infantile Hämangiom: Pathogenese und Wirkmechanismus von propranolol

A Rotter, ZNP de Oliveira - JDDG: Journal der Deutschen …, 2017 - Wiley Online Library
Das infantile Hämangiom (IH) ist der häufigste gutartige Tumor im Kindesalter. Die
Prävalenz beträgt 4% bis 10%. Es ist gekennzeichnet durch eine proliferative schnelle …

[HTML][HTML] The beta adrenergic receptor antagonist propranolol alters mitogenic and apoptotic signaling in late stage breast cancer

A Montoya, A Varela-Ramirez, E Dickerson… - Biomedical journal, 2019 - Elsevier
Background Substantial evidence supports the use of inexpensive β-AR antagonists (beta
blockers) against a variety of cancers, and the β-AR antagonist propranolol was recently …

Propranolol induces regression of hemangioma cells via the down‐regulation of the PI3K/Akt/eNOS/VEGF pathway

WK Pan, P Li, ZT Guo, Q Huang… - Pediatric blood & …, 2015 - Wiley Online Library
Background Infantile hemangioma (IH) is a benign vascular neoplasm resulting from the
abnormal proliferation of endothelial cells and pericytes in infants. Propranolol, a non …

Effectiveness of propranolol in preventing severe retinopathy of prematurity: a comprehensive systematic review and meta-analysis

MA Shafique, A Haseeb, MMN Uddin, B Asghar… - American Journal of …, 2023 - Elsevier
ABSTRACT BACKGROUND One of the most common causes of juvenile blindness that is
avoidable is retinopathy of prematurity (ROP). As more extremely preterm newborns survive …

Propranolol therapy for infantile hemangioma: our experience

L Zhang, HW Wu, W Yuan, JW Zheng - Drug design, development …, 2017 - Taylor & Francis
Objective Hemangiomas are the most common benign vascular tumors of infancy. Although
most infantile hemangiomas (IHs) have the ability to involute spontaneously after initial …

Propranolol therapy in infantile hemangioma: it is not just about the beta

JC Lee, O Modiri, RW England… - Plastic and …, 2021 - journals.lww.com
Background: Propranolol, a nonselective β-adrenergic receptor antagonist, is approved by
the US Food and Drug Administration to treat problematic infantile hemangiomas, but a …

Propranolol targets hemangioma stem cells via cAMP and mitogen-activated protein kinase regulation

NCO Munabi, RW England, AK Edwards… - Stem cells …, 2016 - academic.oup.com
Infantile hemangiomas (IHs) are the most common vascular tumor and arise from a
hemangioma stem cell (HemSC). Propranolol has proved efficacious for problematic IHs …